US Neurostimulation Market:
An Industry Commentary

The market for neurostimulation devices, which employ implanted electrodes to help treat certain nerve-related disorders, is likely to continue growing at an average rate of 16 percent through 2012-- along with increasing proof of efficacy, physician acceptance, an aging population, and the need for treatments that are quicker, safer and less expensive than drug-based therapies. Neurostimulation devices likely to show the greatest growth are those targeting the deep brain, the spinal cord and the sacral area. While current products are relatively straightforward, opportunities and unmet needs include smaller devices that are easier to use, longer battery life and better feedback mechanisms. Advances in remote patient monitoring, wireless technology, and microprocessor hardware may add complexity and utility, thus adding indications. Scientia Advisors recommends that device companies consider developing or purchasing technologies in this growing field.